company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-49800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,71500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,71500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,61900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,53300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,53300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-44500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-25100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,30000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,104500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,47600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,65900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-33900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-65400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-98000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,104500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,88600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,35100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,96400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,96400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,94000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,94000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-95600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-26600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-26600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-42900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-158100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-158100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-75800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,112100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-70900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,84500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,84500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-198000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-195400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-195400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-66100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-83200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,89200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-149600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,115400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,115400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-149700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,222600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,55300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,55300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-305400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-104300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,304900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-97200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-97200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,93400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,93400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-191600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,112500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-108300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-108300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,19900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-53600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-53600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-72800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-29900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-79700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,190300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,154600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,38200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,51800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,146800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,146800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-42700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-48500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-52900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,52000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,91000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,31300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,131300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,131300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-279700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,172300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-131900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-131900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-13100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,174200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-155900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-186900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,167700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-146900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-146900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-50300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,101100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,101100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-92800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,145200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-158300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-107700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,165700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,61600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,90600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,128100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,128100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,85700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-73000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-73000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-133700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-138900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,172400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-89300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-89300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,132200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,132200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-152300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-250300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,372800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,98300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,32100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-453100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,223600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-246900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-246900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-535600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,597300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,21900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,61500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,138900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,138900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-402200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,296800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-80300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,208300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-124700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,211900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,778000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,778000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-755200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,298100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-470400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-470400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-135000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,202900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-105900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-454400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,317700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-154800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-154800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,200300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-48300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,93200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,93200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-505000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,700300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,112000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,112000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,74400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,73300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,73300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-507000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,349200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-71900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-71900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-196800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,39100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-253000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,291400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-78900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,140600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,52600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-320100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-450700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,620800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-175600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-175600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,48500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,178300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-59700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-59700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,49700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-56000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,107100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,107100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,302700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,47300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,47300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-369100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-369100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-217000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,190300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,190300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-41100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,139400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-343100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-343100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,26100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-131500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,50200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,205900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,205900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-48100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-287300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,347700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,275100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,201100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,201100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-63200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-158300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,295300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,80200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,80200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-246400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,228900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,285100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-143200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,128300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,128300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-84700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-167400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,422800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-354400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-437400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,377400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-391300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-391300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,197700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,197700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-670500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,98600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-638200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-638200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-453800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-73800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,608800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,126800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,126800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-311100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,104400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,310800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,310800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,6300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-356800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,192600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,122100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,334200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,363900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,363900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-51900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-140400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,389400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,49300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,49300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-251300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-229000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-229000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,180100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-93800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,151300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,151300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,280800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,40900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,40900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,408700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-181900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,140200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,140200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-52800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,159800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,104900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,104900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-517500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-428300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,680700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-240700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-240700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,78800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,342300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,342300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-85100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-305300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-254200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-254200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-93100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,144800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,121300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,293000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,293000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-154000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,220100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-601500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-272000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-844700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-844700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-540700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-312300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-51800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,341200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,341200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,164700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-88300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-88300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-256300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-231400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-231400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,83000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,437300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,437300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,87500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,459800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,61000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,399400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,399400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-443100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-445300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-445300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4500000.0
